In 2024, Mankind Pharma conducted an environmental assessment and disclosed corporate waste management data in accordance with recognized sustainability reporting standards. The company provided a breakdown of its waste by type (hazardous vs non-hazardous) and treatment method (recovery vs disposal), enabling greater transparency into its waste handling and environmental practices.
Metric (tonnes) | 2024 | 2023 | 2022 | 2021 - 2017 |
---|---|---|---|---|
Total Waste Generated | 0000000 | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Waste Recovered | 0000000 | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Hazardous Waste Generated | 0000000 | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Non-Hazardous Waste Disposed | 0000000 | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
This table provides a simplified preview of selected waste data points. To access the complete dataset with full disclosures and structure, create a free account to purchase the full dataset.
In 2024, Mankind Pharma generated a total of 9,417 metric tonnes of waste.
Of this amount, 0.07% of Mankind Pharma's total waste generated was recovered through methods such as recycling, reuse, or composting, while 3.58% was disposed of through landfilling, incineration, or combustion. The remaining 96.36% was either treated using unspecified methods or not clearly categorized.
In 2024, Mankind Pharma reported a total waste generation of 9,417 metric tonnes, of which 0.07% was recovered through recycling, reuse, or composting. This low recovery rate highlights limited waste diversion and suggests that Mankind Pharma may be relying more heavily on landfill or incineration, underscoring opportunities for stronger resource recovery initiatives.
Since 2024, Mankind Pharma's total waste generation has increased by 20.94%, which may reflect expanding operations, weaker material efficiency, or insufficient waste reduction efforts.
Over the same period, Mankind Pharma's waste recovery rate increased by 32.13%.
In 2024, Mankind Pharma generated a total of 9,417 metric tonnes of waste.
Of this amount, 3.85% of Mankind Pharma's total waste generated of was classified as hazardous waste, characterized by properties such as toxicity, flammability, corrosiveness, or reactivity that may pose risks to human health, ecosystems, or the environment. 96.15% was identified as non-hazardous waste, generally considered less harmful and subject to lighter regulatory controls.
Since 2024, Mankind Pharma's total waste generation has increased by 20.94%, which may reflect expanding operations, weaker material efficiency, or insufficient waste reduction efforts.
Since 2024, Mankind Pharma's hazardous waste generation has increased by 7.03%, indicating a potential rise in the use of harmful materials, process inefficiencies, or limited hazardous waste reduction strategies..
Overall, Mankind Pharma's waste and hazardousness trends are mixed or inconclusive. A more detailed review of its materials, industry standards, and operational changes would help clarify the net environmental impact of its waste strategy.